Enveric Biosciences
ENVB
NASDAQ
IPO1995
about ENVB
Enveric Biosciences is a biotechnology company developing novel, small-molecule therapeutics designed to promote neuroplasticity to treat difficult neuropsychiatric disorders like depression, anxiety, and addiction without the hallucinogenic effects associated with some current approaches.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $8.97 | $10.26 | $8.90 | $3.53M | 520.16K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$10.81 | n/a | 11214.98 | -683920.80% | -683820.80% | 0% |